GLYCOMIMETICS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [•], 20__ Debt SecuritiesIndenture • March 4th, 2022 • Glycomimetics Inc • Pharmaceutical preparations • New York
WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
AND [__________], As Warrant Agent Form of Preferred Stock Warrant Agreement Dated As Of GlycoMimetics, Inc. Form of Preferred Stock Warrant AgreementWarrant Agreement • March 4th, 2022 • Glycomimetics Inc • Pharmaceutical preparations • New York
This Preferred Stock Warrant Agreement (this “Agreement”), dated as of [•], between GlycoMimetics, Inc., a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
GlycoMimetics, Inc. AND [_____________], As Warrant Agent Form of Debt Securities Warrant Agreement Dated As Of [__________] GlycoMimetics, Inc. Form of Debt Securities Warrant AgreementWarrant Agreement • March 4th, 2022 • Glycomimetics Inc • Pharmaceutical preparations • New York
This Debt Securities Warrant Agreement (this “Agreement”), dated as of [•], between GlycoMimetics, Inc., a Delaware corporation (the “Company”), and [•], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [•], as warrant agent (the “Warrant Agent”).
